Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1718758

registered interest
date	16/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pancreatic Cancer: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help improve (a) research into treatments for and (b) (i) emotional and (ii) financial support for people living with pancreatic cancer.
tabling member constituency	Putney
tabling member printed	Fleur Anderson
uin	26771
answer	answer is ministerial correction date of answer 23/05/2024 answer text <p>Research is crucial in tackling cancer, which is why the Department invests £1.3 billion per year in health research, through the National Institute for Health and Care Research (NIHR). NIHR research expenditure for all cancers was £121.8 million in 2022/23, and the NIHR spends more on cancer than any other disease group. <br> <br> The NIHR funded nine research projects on pancreatic cancer since 2018/19, with a committed funding value of £4.3 million. The NIHR continues to welcome funding applications for research into any aspect of human health, including pancreatic cancer. Applications are subject to peer review and judged in open competition. <br> <br> The NIHR also supports delivery of research into pancreatic cancer in the health and care system, funded by research funding partners in the charity and public sectors. Since 2018/19 the NIHR supported 73 clinical research studies through the Clinical Research Network. <br> <br> Additionally, NIHR Biomedical Research Centres (BRC) and NIHR Clinical Research Facilities spent a further £6.5 million between 2018/19 and 2022/23, supporting an annual portfolio of approximately 85 early clinical studies into pancreatic cancer. NIHR BRCs are collaborations between world-leading universities and National Health Service organisations, that bring together academics and clinicians to translate discoveries from basic or discovery science into clinical research. <br> <br> For emotional and financial support, patient feedback is monitored through the National Cancer Patient Experience Survey, with the latest results showing an overall experience of 8.88 out of 10. In areas such as support for health and wellbeing, and information on financial help, results were positive but showed room for improvement. NHS England continues to support trusts to take action to improve cancer patient support.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 23/05/2024 08:21:01 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4788 label Biography information for Fleur Anderson

1718766

registered interest
date	16/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Breast Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if she will make an assessment of the potential merits of offering breast cancer screening to women going through early menopause.
tabling member constituency	Putney
tabling member printed	Fleur Anderson
uin	26776
answer	answer is ministerial correction date of answer 21/05/2024 answer text <p>The UK National Screening Committee (UK NSC) currently recommends that all women aged 50 to 71 years old are invited for a breast screening every three years. The AgeX trial is looking at the impact of increasing or decreasing the screening age for breast screening, and the UK NSC will review its findings when they are available.</p><p>The UK NSC can be alerted to any new published peer reviewed evidence which may suggest the case for a new screening programme, or changes to an existing one. Proposals can be submitted via the UK NSC’s annual call in July 2024, which is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/uk-nsc-annual-call-submitting-a-screening-proposal/uk-nsc-annual-call-how-to-submit-a-proposal#:~:text=To%20submit%20a%20proposal%20for,your%20name" target="_blank">https://www.gov.uk/government/publications/uk-nsc-annual-call-submitting-a-screening-proposal/uk-nsc-annual-call-how-to-submit-a-proposal#:~:text=To%20submit%20a%20proposal%20for,your%20name</a></p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 21/05/2024 16:51:28 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4788 label Biography information for Fleur Anderson

1718802

registered interest
date	16/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bipolar Disorder: Diagnosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps her Department have taken to reduce the time taken from initial presentation of symptoms to diagnosis of bipolar disorder.
tabling member constituency	Leeds North West
tabling member printed	Alex Sobel
uin	26719
answer	answer is ministerial correction date of answer 22/05/2024 answer text <p>We’re set to reach nearly £1 billion of additional funding invested by 2023/24, compared to 2018/19, to transform community mental health services. In 2022/23, 288,000 people with severe mental illness, including bipolar disorder, accessed support through new integrated models of community care.</p><p>The funding aims to increase access to high quality care and transform care pathways for people with severe mental illness, including bipolar disorder, through: greater integration of primary and community services, to provide care in the community driven by the needs of individuals, rather than based solely on diagnoses; physical health checks; and Individual Placement and Support schemes, as well as Early Intervention in Psychosis services.</p><p>NHS England is also working on implementing new access and waiting time standards for mental health services, including one for adults with bi-polar disorder or similar, to start to receive community-based mental health care within four weeks of referral.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 22/05/2024 09:28:15 answering member 4492 label Biography information for Maria Caulfield
tabling member	4658 label Biography information for Alex Sobel

1718804

registered interest
date	16/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Chronic Fatigue Syndrome: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether her Department (a) has and (b) plans to provide funding for new treatments for ME or chronic fatigue syndrome.
tabling member constituency	Leeds North East
tabling member printed	Fabian Hamilton
uin	26662
answer	answer is ministerial correction date of answer 21/05/2024 answer text <p>The Department, through the National Institute for Health and Care Research (NIHR), provides funding for research projects which aim to understand the underlying causes of myalgic encephalomyelitis, also known as chronic fatigue syndrome (ME/CFS), and find new treatments for the condition. As part of this, the NIHR and the Medical Research Council have funded the world’s largest genome-wide association study of ME/CFS. This £3.2 million study, termed DecodeME, will analyse samples from 25,000 people with ME/CFS to search for genetic differences that may indicate underlying causes, or an increased risk of developing the condition. By helping us to understand ME/CFS better, this research has the potential to lead to new treatments for the condition.</p><p>Integrated care boards (ICBs) are responsible for commissioning specialist ME/CFS services that meet the needs of their population, subject to local prioritisation and funding. The process of commissioning services should take into account best practice guidance, such as the National Institute for Health and Care Excellence’s guidance on ME/CFS diagnosis and management, published in October 2021. In addition, in October 2023, the British Association of Clinicians in ME/CFS published the ME/CFS National Services Survey. This report provides insight into the services being delivered for adults, children, and young people with ME/CFS.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 26663 question first answered 21/05/2024 08:08:03 answering member 4044 label Biography information for Andrew Stephenson
tabling member	415 label Biography information for Fabian Hamilton

1718234

registered interest
date	15/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Vaccine Damage Payment Scheme: Reviews
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the terms of reference are for her Department's review of the vaccine damage compensation scheme; which body is responsible for undertaking the review; and what estimate she has made of when the review will be completed.
tabling member constituency	Christchurch
tabling member printed	Sir Christopher Chope
uin	26322
answer	answer is ministerial correction date of answer 22/05/2024 answer text <p>All routine policy, including the Vaccine Damage Payment Scheme (VDPS), is reviewed on a regular basis. My Rt hon. Friend, the Secretary of State for Health and Social Care is currently looking into aspects of the scheme, following recent meetings with interested stakeholders.</p><p>Separately, work is underway with the scheme’s administrator, the NHS Business Service Authority, to review processes and make administrative changes, to improve the scheme within the current legislative framework. Formal consideration of whether any reforms to the VDPS are necessary will form part of Module 4 of the COVID-19 Inquiry, chaired by the Rt Hon Baroness Heather Carol Hallett DBE.</p> answering member constituency Lewes answering member printed Maria Caulfield grouped question UIN 26628 26635 26636 question first answered 22/05/2024 10:43:11 answering member 4492 label Biography information for Maria Caulfield previous answer version 35275 answering member constituency Lewes answering member printed Maria Caulfield answering member 4492 label Biography information for Maria Caulfield
tabling member	242 label Biography information for Sir Christopher Chope

1718235

registered interest
date	15/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Mental Health Services: Private Sector
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment she has made of the (a) prevalence of the use of, (b) adequacy of the standards of service provided by and (c) potential impact on patient outcomes of the use of the private sector in the provision of mental health services in the NHS; and what steps she has taken to help ensure compliance by the private sector with the Code of Practice: Mental Health Act 1983.
tabling member constituency	Halton
tabling member printed	Derek Twigg
uin	26363
answer	answer is ministerial correction date of answer 20/05/2024 answer text <p>No such specific assessment has been made. Private companies have always played a role in the National Health Service, and patients should expect a safe and good quality service regardless of whether their care is delivered by private sector or public sector providers. Local integrated care boards are responsible for commissioning health and care services for their local populations, in line with the standards set out in the NHS Standard Contract.</p><p>The Care Quality Commission is the independent regulator of health and care services. All providers of regulated activities, including those in the private sector, must register with the Care Quality Commission, and follow a set of fundamental standards of safety and quality, below which care should never fall.</p><p>The Care Quality Commission also has a duty under the Mental Health Act 1983 to monitor how services exercise their powers and discharge their duties under the act when patients are detained in hospital or are subject to community treatment orders or guardianship.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 20/05/2024 17:05:21 answering member 4492 label Biography information for Maria Caulfield
tabling member	429 label Biography information for Derek Twigg

1718277

registered interest
date	15/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pancreatic Cancer: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps she is taking to ensure that patients taking pancreatic enzymes continue to receive them.
tabling member constituency	Walthamstow
tabling member printed	Stella Creasy
uin	26452
answer	answer is ministerial correction date of answer 20/05/2024 answer text <p>We are aware of supply issues with three pancreatic enzyme replacement therapies: Creon 10000 gastro-resistant capsules; Creon 25000 gastro-resistant capsules; and Nutrizym 22 gastro-resistant capsules. We understand that these are due to limited availability of active pharmaceutical ingredients, and manufacturing constraints in producing the volumes required to meet demand. The Department has issued guidance to healthcare professionals regarding treatment of patients while there is a disruption to the supply of these pancreatic enzyme replacement therapies. We are having regular conversations with the suppliers of these products, to ask that they expedite deliveries and increase production forecasts, and to confirm that they are taking action to address the root causes of the issues, to ensure continuity of supply. We are also working with specialist importers to source unlicensed imports from abroad.</p><p>Whilst we can’t always prevent supply issues, we have a range of well-established tools and processes to mitigate risks to patients. These include close and regular engagement with suppliers, use of alternative strengths or forms of a medicine to allow patients to remain on the same product, expediting regulatory procedures, sourcing unlicensed imports from abroad, adding products to the restricted exports and hoarding list, use of Serious Shortage Protocols, and issuing National Health Service communications to provide management advice and information on the issue to healthcare professionals, so they can advise and support their patients.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 20/05/2024 16:55:17 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4088 label Biography information for Stella Creasy

1718283

registered interest
date	15/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Mental Health Services: Veterans
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many veterans are on a waiting list for mental health treatment.
tabling member constituency	Birmingham, Selly Oak
tabling member printed	Steve McCabe
uin	26328
answer	answer is ministerial correction date of answer 22/05/2024 answer text <p>The information requested is not held centrally by NHS England. Veterans are not systematically identified in National Health Service systems, and therefore it is not possible to confirm how many veterans are on waiting lists for NHS services.</p> answering member constituency Lewes answering member printed Maria Caulfield grouped question UIN 26329 26330 question first answered 22/05/2024 08:22:08 answering member 4492 label Biography information for Maria Caulfield
tabling member	298 label Biography information for Steve McCabe

1718284

registered interest
date	15/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dental Services: Veterans
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many veterans are on a waiting list for dental care.
tabling member constituency	Birmingham, Selly Oak
tabling member printed	Steve McCabe
uin	26329
answer	answer is ministerial correction date of answer 22/05/2024 answer text <p>The information requested is not held centrally by NHS England. Veterans are not systematically identified in National Health Service systems, and therefore it is not possible to confirm how many veterans are on waiting lists for NHS services.</p> answering member constituency Lewes answering member printed Maria Caulfield grouped question UIN 26328 26330 question first answered 22/05/2024 08:22:08 answering member 4492 label Biography information for Maria Caulfield
tabling member	298 label Biography information for Steve McCabe

1718285

registered interest
date	15/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services: Veterans
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many physically injured veterans are on a waiting list for rehabilitative care.
tabling member constituency	Birmingham, Selly Oak
tabling member printed	Steve McCabe
uin	26330
answer	answer is ministerial correction date of answer 22/05/2024 answer text <p>The information requested is not held centrally by NHS England. Veterans are not systematically identified in National Health Service systems, and therefore it is not possible to confirm how many veterans are on waiting lists for NHS services.</p> answering member constituency Lewes answering member printed Maria Caulfield grouped question UIN 26328 26329 question first answered 22/05/2024 08:22:08 answering member 4492 label Biography information for Maria Caulfield
tabling member	298 label Biography information for Steve McCabe